BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18566674)

  • 1. Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis.
    Holm R; de Putte GV; Suo Z; Lie AK; Kristensen GB
    Int J Med Sci; 2008 Jun; 5(3):121-6. PubMed ID: 18566674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
    Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
    Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.
    Xu F; Zhong W; Li J; Shanshen Z; Cui J; Nesland JM; Suo Z
    Anticancer Res; 2005; 25(4):2943-50. PubMed ID: 16080548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.
    Holm R; Knopp S; Suo Z; Tropè C; Nesland JM
    J Clin Pathol; 2007 Oct; 60(10):1086-91. PubMed ID: 17158642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
    Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z
    Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and prognostic significance of EphA2 and EphrinA-1 in ovarian serous carcinomas].
    Han LP; Liu JF; Liu XR; Dong ZM; Suo ZH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):179-84. PubMed ID: 21500549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients.
    Yuan WJ; Ge J; Chen ZK; Wu SB; Shen H; Yang P; Hu B; Zhang GW; Chen ZH
    Dig Dis Sci; 2009 Nov; 54(11):2410-7. PubMed ID: 19101799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions of angiogenesis-related factors: CD105, EphA2 and EphrinA1 in laryngeal squamous cell carcinoma and clinical implication].
    Su J; Ji XB; Xie JH; Li W
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):929-936. PubMed ID: 27978884
    [No Abstract]   [Full Text] [Related]  

  • 9. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
    Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
    Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.
    Herath NI; Spanevello MD; Sabesan S; Newton T; Cummings M; Duffy S; Lincoln D; Boyle G; Parsons PG; Boyd AW
    BMC Cancer; 2006 Jun; 6():144. PubMed ID: 16737551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor hypoxia, p53, and prognosis in cervical cancers.
    Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma.
    Straume O; Akslen LA
    Br J Cancer; 2005 Oct; 93(8):933-8. PubMed ID: 16189525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
    Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
    Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
    Zhang Y; Yan M; He J; Sun J; Sun X
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Cytokeratin 19 and Squamous Cell Cancer Antigen in Histologically Negative Sentinel Lymph Nodes of Cervical Squamous Cell Carcinoma.
    Ren J; Zhou ZL; Xu S; Yang YJ
    Int J Gynecol Cancer; 2016 Nov; 26(9):1679-1685. PubMed ID: 27654256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Fukuchi M; Nakajima M; Kuwano H
    Int J Cancer; 2003 Feb; 103(5):657-63. PubMed ID: 12494475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome.
    Shao Z; Zhang WF; Chen XM; Shang ZJ
    Oral Oncol; 2008 Dec; 44(12):1110-7. PubMed ID: 18485799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma.
    Zhang LY; Han CS; Li PL; Zhang XC
    Jpn J Clin Oncol; 2016 May; 46(5):427-34. PubMed ID: 26851753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathologic significance of laminin-5 gamma2 chain expression in cervical squamous carcinoma and adenocarcinoma.
    Andersson S; Hellström AC; Angström T; Stendahl U; Auer G; Wallin KL
    Int J Gynecol Cancer; 2005; 15(6):1065-72. PubMed ID: 16343183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.